EUROPEAN VENOUS FOUNDATION
To develop education, scientific knowledge, research and clinical expertise of the highest quality and establish standards in the field of venous disease.To promote collaboration between phlebological societies, health agencies and authorities at national and European level.To organise congresses, seminars, research and provide research grants.
Objects
THE PROMOTION OF RESEARCH INTO THE CAUSES, EFFECTS, TREATMENT AND MANAGEMENT OF VENOUS DISEASES AND TO DISSEMINATE THE USEFUL RESULTS THEREOF.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds were £746,645 at the balance sheet date, which the trustees describe as healthy and above expected levels. The trustees confirm that budgeted income and expenditure, combined with current reserves, are sufficient for the charity to continue as a going concern for the next 12 months.
What the accounts disclose
“Itis the policy of the charity to maintain unrestricted funds at a reasonable level to provide sufficient funds to cover management and administration support costs to continue the educational activities.” — page 5
“Included in other debtors is the amount of £132,263 which is a loan made to European Venous Forum Ltd, a company which some of the trustees are the directors.” — page 12
“Included in other debtors is the amount of £132,263 which is a loan made to European Venous Forum Ltd, a company which some of the trustees are the directors.” — page 12
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Corporate structure
- Trading subsidiary: EUROPEAN VENOUS FORUM LIMITED Companies House 04354339
Trustees
- PROFESSOR ANDREAS NICOLAIDESchair
- ANNE TAFT
- Dr ARKADIUSZ JAWIEN MD
- Dr Armando Amilcar Pires Mansilha Rodrigues de Almeida
- Dr Dominik Heim
- Dr MARIANNE VANDENDRIESSCHE-HOBBS
- Dr Marzia Lugli
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £42k | £81k |
| 31/12/2024 | £35k | £61k |
| 31/12/2023 | £45k | £22k |
| 31/12/2022 | £40k | £13k |
| 31/12/2021 | £30k | £18k |
Common questions
Is EUROPEAN VENOUS FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds were £746,645 at the balance sheet date, which the trustees describe as healthy and above expected levels. The trustees confirm that budgeted income and expenditure, combined with current reserves, are sufficient for the charity to continue as a going concern for the next 12 months. Its FY2025 accounts were independently examined.